Literature DB >> 1843260

Myopathic changes in indirectly stimulated mouse diaphragm after ecothiopate in vitro.

C B Ferry1, M J Cullen.   

Abstract

Mouse phrenic nerve-hemidiaphragms were stimulated in vitro in the presence of the anticholinesterase ecothiopate iodide and prepared for light and electron microscopy at different times during and after the appearance of prolonged contractions localized at the endplate. The earliest changes were at the subsynapse, without damage to the plasma membrane, and comprised hypercontraction of the sarcomeres, dilatation and vesiculation of the sarcoplasmic reticulum and the mitochondria, and dissolution of the Z-lines. Later there was damage to the plasma membrane. Also appearing later in the junctional region, but separated from the subsynapse by apparently normal muscle, were extrasynaptic hypercontractions, with a plasma membrane initially undamaged, but which became permeable after the contractile material divided into contraction clots. A hypothesis is proposed for the formation of such hypercontractions by abnormal mechanical factors arising from different contractile states along the length of the fibre, and is discussed with the role of prolonged transmitter action in the aetiology of myopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1843260      PMCID: PMC2001941     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  10 in total

1.  Reactions of the normal mammalian muscle to acetylcholine and to eserine.

Authors:  G L Brown; H H Dale; W Feldberg
Journal:  J Physiol       Date:  1936-09-08       Impact factor: 5.182

2.  Chronic inhibition of cholinesterase as a cause of myopathy.

Authors:  G M Fenichel; W B Kibler; W H Olson; W D Dettbarn
Journal:  Neurology       Date:  1972-10       Impact factor: 9.910

3.  Accumulation of extracellular calcium at the endplate of mouse diaphragm after ecothiopate in vitro.

Authors:  P F Burd; C B Ferry; J W Smith
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

4.  Comparison of the ultrastructural myopathy induced by anticholinesterase agents at the end plates of rat soleus and extensor muscles.

Authors:  C K Meshul; A F Boyne; S S Deshpande; E X Albuquerque
Journal:  Exp Neurol       Date:  1985-07       Impact factor: 5.330

5.  The site of action of corticosteroid antipyresis in the rabbit.

Authors:  G H Willies; C J Woolf
Journal:  J Physiol       Date:  1980-03       Impact factor: 5.182

6.  The origin of the anticholinesterase-induced repetitive activity of the phrenic nerve-diaphragm preparation of the rat in vitro.

Authors:  C B Ferry
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

7.  Studies of sarcolemmal integrity in myopathic muscle.

Authors:  W G Bradley; J J Fulthorpe
Journal:  Neurology       Date:  1978-07       Impact factor: 9.910

8.  A light and electron microscopic histochemical study on the mechanism of DFP-induced acute and subacute myopathy.

Authors:  L Tóth; S Karcsú; M Poberai; G Sávay
Journal:  Neuropathol Appl Neurobiol       Date:  1981 Sep-Oct       Impact factor: 8.090

9.  A physiological role for titin and nebulin in skeletal muscle.

Authors:  R Horowits; E S Kempner; M E Bisher; R J Podolsky
Journal:  Nature       Date:  1986 Sep 11-17       Impact factor: 49.962

10.  A network of transverse and longitudinal intermediate filaments is associated with sarcomeres of adult vertebrate skeletal muscle.

Authors:  K Wang; R Ramirez-Mitchell
Journal:  J Cell Biol       Date:  1983-02       Impact factor: 10.539

  10 in total
  2 in total

1.  Protection against the effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles.

Authors:  S S Kelly; C B Ferry; J P Bamforth; S K Das
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  "Calcium bombs" as harbingers of synaptic pathology and their mitigation by magnesium at murine neuromuscular junctions.

Authors:  Kosala N Dissanayake; Robert R Redman; Harry Mackenzie; Michael Eddleston; Richard R Ribchester
Journal:  Front Mol Neurosci       Date:  2022-07-26       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.